Sindhi family buys 10 flats for Rs 232 cr in Omkar's luxury Worli project
Virat Kohli, Yuvraj Singh, Baba Kalyani have also bought flats in project12-04-2017
12-04-2017
Certificate Under Regulation 40 (9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 40(9) & 40(10) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the certificate for the period ended 31st March, 2017 issued to us by Mr.S.V. Deulkar, Practicing Company Secretary, Pune' received by us today. Please take the said certificate on your records.11-04-2017
Viraj Kalyani launches entrepreneurial venture
Viraj Kalyani, Executive Director, Kalyani Forge (KFL), and industrialist Baba Kalyani's nephew, has launched his entrepreneurial venture, Kalyani Studio. The engineering and designing (E&D)...10-04-2017
Statement Of Investor Complaint For The Quarter Ended March 31, 2017
In terms of Regulation 13(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, following are the details of Investor Complaint(s) pending, received, disposed off and remaining unresolved for the quarter ended on 31st March, 2017 : Sr. No.Particulars of Investor Complaints No. of Complaints 1Pending at the beginning of the quarterNil 2Received during the quarterTwo 3Disposed off during the quarterTwo...10-04-2017
Kalyani Steel's gains going forward will be hard-won
Kalyani Steels (KSL), which manufactures steel long products, had seen respectable Q3 results, but the double-digit net profit growth numbers - yoy net profit grew 31% - doesn't disguise the fact that profit growth is lower than historical averages due to increasingly expensive inputs - the prices of iron ore and coking coal have shot up, putting pressure on the company's margins. The falling rupee has also increased costs, since almost all coking coal is imported into the country. The company is likely to maintain its margins nevertheless, due to cost reductions and volume growth - and India’s projected growth at 7% or more over the next year, and the strong infrastructure focus in the Budget, with priority on domestic steel, should benefit Kalyani. India has also upped its defence spending, another plus for the company. Analysts such as BOB Capital Markets expect KSL to grow at a CAGR of approximately 10% over FY16-19E - the analyst take is that this remains a strong stock for medium and long-term investors, with "limited upside" for the short-term. KSL has been trading above all its averages, up 147% from its 52 week low.19-03-2017
Standalone Financial Results, Limited Review Report for December 31, 2016
Kalyani Steels Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 20162. Standalone Limited Review for the period ended December 31, 201609-02-2017
Board Meeting Intimation for Results & Closure of Trading Window
Kalyani Steels Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled to be held on February 09, 2017, inter alia, to consider and approve the Standalone Unaudited Financial Results for the quarter and nine months ended December 31, 2016.Further, as per the Company's Code of Conduct for Prevention of Insider Trading, the trading window for dealing in the securities of the Company will remain closed for...30-01-2017
Shareholding for the Period Ended December 31, 2016
Kalyani Steels Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click here17-01-2017
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
Kalyani Steels Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.12-01-2017
Standalone Financial Results, Limited Review Report for September 30, 2016
Kalyani Steels Ltd has informed BSE about : 1. Standalone Financial Results for the period ended September 30, 20162. Standalone Limited Review for the period ended September 30, 201621-10-2016